For decades, the American healthcare landscape has operated under a persistent, narrow misconception: that women’s health is synonymous with maternity and reproductive family planning. While these services remain vital, they represent only a fraction of the actual medical requirements for the average woman. Today, women’s health has emerged as one of the largest, most inefficient, and most overlooked cost categories for employers, health plans, and third-party benefit administrators.
When viewed through a holistic lens—encompassing chronic conditions, hormonal health, and systemic care—women’s health rivals the financial weight of cardiometabolic and musculoskeletal conditions. Yet, because the current fee-for-service model treats symptoms in isolation rather than addressing the patient as a whole, it is fueling a crisis of inefficiency, ballooning costs, and compromised patient outcomes.
The Myth of the “One-Time Event”
The prevailing systemic failure begins with a misunderstanding of the female patient journey. Over 60 percent of women in midlife are actively managing chronic conditions that require consistent monitoring, proactive management, and integrated care.
However, the current fee-for-service architecture is designed to address acute, isolated issues. When a woman presents with a complex set of symptoms, the system "bounces" her between disconnected specialists. Rather than a primary care physician or a dedicated care team looking at the full clinical picture to determine an evidence-based treatment path, the patient becomes a collection of billing codes. This fragmented approach inevitably results in delayed diagnoses, a cycle of duplicate testing, unnecessary imaging, and a systemic bias toward invasive surgical procedures that are often far more expensive—and potentially more traumatic—than conservative alternatives.
Chronology of a Failed Care Journey: Two Case Studies
To understand the gravity of this systemic dysfunction, one must look at the actual patient experience. The following scenarios represent the standard, rather than the exception, in modern American healthcare.
The Menopause Gauntlet
Consider a woman in her early fifties beginning to experience the perimenopausal transition. Her symptoms are multifaceted: irregular periods, intense hot flashes, persistent anxiety, sleep disturbances, debilitating joint pain, and "brain fog."
- The Wait: First, she faces an average wait time of 41 days just to secure an initial appointment with an OB/GYN.
- The Fragmentation: Once she enters the system, she is referred across a labyrinthine network of providers. She visits a primary care doctor for cognitive issues, an OB-GYN for her cycle, a sleep specialist for insomnia, an endocrinologist for hormonal fluctuations, a psychiatrist for anxiety, and an orthopedist for her joints.
- The Outcome: Each of these specialists operates in a silo. Each orders their own tests, imaging, and prescriptions. What could have been managed through a single, coordinated, and holistic care plan—addressing hormonal balance and lifestyle modification—becomes a years-long diagnostic odyssey. The cost to the health system, in terms of both claims and administrative burden, is astronomical.
The Fibroid Escalation
The pattern is equally concerning for younger patients. Take, for instance, a woman in her mid-30s suffering from uterine fibroids and heavy menstrual bleeding. She is chronically fatigued, struggling to maintain her job performance, and experiencing a significant decline in quality of life.
- The Initial Response: She waits months for a specialist, who prescribes oral contraceptives as a "first and only" measure.
- The Crisis: When this conservative, singular approach fails to address the root cause, the condition worsens. Eventually, she presents to the emergency room with severe anemia, requiring a blood transfusion—a high-cost, high-acuity event that could have been avoided.
- The Escalation: Following years of trial and error, the path of least resistance in the current system is often surgical: endometrial ablation or a hysterectomy. While these surgeries have their place, they are frequently reached without ever exploring evidence-based, proactive medical management—such as targeted iron supplementation or anti-inflammatory protocols—that could have altered her trajectory years earlier.
Supporting Data: The Hidden Financial Drain
The financial burden of this fragmented care is rarely itemized. Because women’s health costs are not grouped into a single "episode of care," they remain invisible within claims data.
Billing codes are disparate and scattered across multiple providers and various years. An employer or a health insurer might see a claim for an orthopedist here, a pharmacy script there, and a lab test elsewhere. Because these data points are never aggregated, it is impossible for payers to identify true cost drivers or hold providers accountable for long-term health outcomes.
This lack of visibility creates a "compounding risk." As healthcare spend rises, there is no clear strategy to manage it because the system is essentially operating blind. For women, this translates into significant out-of-pocket expenses and a massive "time tax"—the hours lost to unnecessary appointments, coordinating their own care, and navigating conflicting medical advice.
Implications for Employers and Payers
For the stakeholders funding this system, the status quo is unsustainable. Employers are essentially subsidizing a model that encourages inefficiency. By failing to integrate care, they are paying for duplicate services that do not improve the health of their workforce.
The Path Toward Reform
To bend the cost curve, employers and payers must facilitate a fundamental shift in how care is delivered and incentivized. This involves several critical building blocks:
- Unified Data Strategy: Payers must move toward data architectures that aggregate women’s health claims, allowing for the identification of patterns rather than isolated billing events.
- Virtual-First Integrated Models: Moving toward "virtual-first" care teams allows for a more cohesive experience where a single point of contact (or a unified team) manages the patient’s full clinical picture, reducing the need for disjointed specialist visits.
- Value-Based Care Incentives: Moving away from fee-for-service toward value-based models encourages providers to prioritize conservative, evidence-based management over high-cost, high-volume procedures.
- Proactive Care Navigation: Empowering patients with a "clinical quarterback" who can interpret conflicting guidance and coordinate appointments reduces the administrative and financial burden on the patient.
Conclusion: Turning Invisibility into Opportunity
The old adage in business remains true in healthcare: You cannot manage what you cannot see. Today, women’s health costs are largely hidden in the shadows of an antiquated, fragmented system.
By creating a unified view of the patient’s journey, stakeholders have the power to turn a massive, hidden cost center into one of the most significant opportunities for financial improvement and clinical success. The transition from a reactive, fragmented system to a proactive, integrated model is not merely a moral imperative for women’s health; it is a financial necessity for a sustainable healthcare system. The future of healthcare delivery depends on our ability to see the full picture—and for millions of women, that clarity cannot come soon enough.
About the Authors
Chevon Rariy, MD, DABOM, is the Chief Medical Technology Officer at Visana Health. She leads clinical strategy and innovation, focusing on expanding virtual-first, evidence-based care across gynecology, hormonal health, and comorbid chronic conditions.
Kara Ellinger is a veteran insurance executive and former VP of commercial product at Anthem. She currently serves as a strategic advisor to organizations dedicated to transforming the women’s health landscape.
This post appears through the MedCity Influencers program. Perspectives expressed are those of the authors.
